Neurobiología Celular y Molecular, Instituto Clemente Estable (IIBCE), 3318, Italia Av, 11600, Montevideo, Uruguay.
Departmento de Histología y Embriología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Mol Neurobiol. 2019 Nov;56(11):7694-7707. doi: 10.1007/s12035-019-1620-4. Epub 2019 May 18.
Glutaric acidemia I (GA-I) is an inherited neurometabolic childhood disease characterized by bilateral striatal neurodegeneration upon brain accumulation of millimolar concentrations of glutaric acid (GA) and related metabolites. Vascular dysfunction, including abnormal cerebral blood flow and blood-brain barrier damage, is an early pathological feature in GA-I, although the affected cellular targets and underlying mechanisms remain unknown. In the present study, we have assessed the effects of GA on capillary pericyte contractility in cerebral cortical slices and pericyte cultures, as well as on the survival, proliferation, and migration of cultured pericytes. GA induced a significant reduction in capillary diameter at distances up to ~ 10 μm from the center of pericyte somata. However, GA did not affect the contractility of cultured pericytes, suggesting that the response elicited in slices may involve GA evoking pericyte contraction by acting on other cellular components of the neurovascular unit. Moreover, GA indirectly inhibited migration of cultured pericytes, an effect that was dependent on soluble glial factors since it was observed upon application of conditioned media from GA-treated astrocytes (CM-GA), but not upon direct GA addition to the medium. Remarkably, CM-GA showed increased expression of cytokines and growth factors that might mediate the effects of increased GA levels not only on pericyte migration but also on vascular permeability and angiogenesis. These data suggest that some effects elicited by GA might be produced by altering astrocyte-pericyte communication, rather than directly acting on pericytes. Importantly, GA-evoked alteration of capillary pericyte contractility may account for the reduced cerebral blood flow observed in GA-I patients.
戊二酸血症 I 型(GA-I)是一种遗传性神经代谢性儿童疾病,其特征是脑内戊二酸(GA)及其相关代谢物积聚到毫摩尔浓度时,双侧纹状体神经退行性变。血管功能障碍,包括脑血流异常和血脑屏障损伤,是 GA-I 的早期病理特征,尽管受影响的细胞靶标和潜在机制尚不清楚。在本研究中,我们评估了 GA 对大脑皮质切片和周细胞培养物中毛细血管周细胞收缩性的影响,以及对培养周细胞的存活、增殖和迁移的影响。GA 诱导距离周细胞体中心最多约 10μm 的毛细血管直径显著减小。然而,GA 并未影响培养周细胞的收缩性,这表明切片中引发的反应可能涉及 GA 通过作用于神经血管单元的其他细胞成分来引发周细胞收缩。此外,GA 间接抑制了培养周细胞的迁移,这种作用依赖于可溶的神经胶质因子,因为它在给予 GA 处理的星形胶质细胞条件培养基(CM-GA)时观察到,但在直接向培养基中添加 GA 时未观察到。值得注意的是,CM-GA 显示出细胞因子和生长因子的表达增加,这些因子可能不仅介导 GA 水平升高对周细胞迁移的影响,而且还介导血管通透性和血管生成的影响。这些数据表明,GA 引起的一些作用可能是通过改变星形胶质细胞-周细胞通讯产生的,而不是直接作用于周细胞。重要的是,GA 诱发的毛细血管周细胞收缩性改变可能是 GA-I 患者脑血流减少的原因。